JOIN NOW

Why not join CURE today?
Individual memberships welcome!

Good for bioscience in Connecticut. Good for you.
JOIN NOW

The CURE Calendar


Dec
12
Mon
Business of Biotech @ Alexion Pharmaceuticals
Dec 12 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Dec
13
Tue
CURE Holiday Party @ Alexion
Dec 13 @ 5:00 pm – 7:00 pm

unnamed-1

Celebrate the Holidays with
Connecticut’s Bioscience Community!

* Great Networking  

* Festive Hors d’Oeuvres Courtesy of Cafe George by Paula

* Wonderful Wines by Grand Vin


Who will be next? The recipient of the 2016 CURE Entrepreneur of the Year Award will be announced. Thank you to our award sponsor Shipman & Goodwin.

Parking options:

* Air Rights Garage: http://nhparking.com/DETAILS.aspx?id=3&zoom=14 

* Temple Street Garage: http://nhparking.com/DETAILS.aspx?id=17&zoom=14 

* Crown Street Garage: http://www.nhparking.com/DETAILS.aspx?id=8&zoom=14

Thank you to our event sponsors:


Fortunato

 

Jan
25
Wed
Business of Biotech @ Alexion Pharmaceuticals
Jan 25 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Feb
15
Wed
Business of Biotech @ Alexion Pharmaceuticals
Feb 15 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Apr
19
Wed
Business of Biotech @ Alexion Pharmaceuticals
Apr 19 @ 5:30 pm – 7:30 pm

Business of Biotech is a workshop series that will introduce grad students, postdocs and faculty from Yale and UConn to the core skills and building blocks to translate their research to the marketplace.

The series will launch Sept. 19-21 followed by monthly scheduled workshops, all hosted at Alexion. The series will bring in investors, biotech entrepre­neurs, legal experts and others to provide guidance, hands-on workshops and case studies on topics like business plans and funding for life science companies; intellectual property and regulatory considerations; marketing; case studies in life science entrepreneurship; FDA approval; trends in life science funding and exits and more.

Presented by the Office of Cooperative Research and Yale Entrepreneurial Institute with support from the Yale Healthcare and Lifesciences Club, Canaan Partners, Wilson Sonsini Goodrich & Rosati, Jackson Labs and Alexion Pharmaceuticals.

Schedule:

MON., SEPT. 19, 5:30-7:30pm: “Elements of a Business Plan and Sources of Capital for Early Stage Life Science Companies” with Colleen Cuffaro, Associate at Canaan Partners.Guest speakers for case studies include: Jason Hafler, Senior Director of Investments and Principal at Sanofi-Genzyme BioVentures; Susan Froshauer, President & CEO of Connecticut United for Research Excellence; Arthur Hiller, CEO of ENB Therapeutics and CEO of Antyllus Therapeutics, Inc; Lou Degennaro, President of Leukemia & Lymphoma Society.

TUES., SEPT. 20, 5:30-7:30pm: “Intellectual Property and Regulatory Considerations for Early Stage Life Science Companies” with Craig Kenesky, Associate Patent Attorney at WSGR. Guest speakers for case studies include: Erika Smith, Director of the Blavatnik Fund for Innovation at Yale; Cameron Pitt, Investment Professional at Versant Ventures and Associate at Highline Therapeutics; Angela Shen, CMO of Arvinas Inc.

WED., SEPT. 21, 5:30-7:30pm: “Marketing and Operations Considerations for Early Stage Life Science Companies” with Andrey Antov, Program Director of the Maine Cancer Genomics Initiative at The Jackson Laboratory. Guest speakers for case studies include:Daniel Wagner, Managing Director of Investments of Connecticut Innovations; Daniel Passeri, CEO of Context Pharma.

OTHER DATES:

October 19, 5:30-7:30pm: Case Studies in Life Science Entrepreneurship

November 16, 5:30-7:30pm: Tech Transfer – IP & Licensing

December 12, 5:30-7:30pm (Please note Monday!): FDA Approval and Regulatory Issues

January 25, 5:30-7:30pm: Trends in Life Science Funding & Exits, Corporate Strategy & Business Development

February 15, 5:30-7:30pm: Payors & Reimbursement

April 19, 5:30-7:30pm: Medical Devices/Diagnostics & Health IT

Serial Entrepreneur: David Scheer

Biotech Entrepreneur Kevin Rakin:
The Business of Science

A CT Bioscience Entrepreneur’s
Story: Craig M. Crews, Ph.D.

video-icon-Crews-200px

Partner Videos

Yale Video “Innovation to Impact: Dr. Lieping Chen and NextCure”

video-icon-nextcure2016-200x113px

Talent Wanted/Talent Available

> Connecticut BioScience Job Listings
> BioScience Résumés

Click Here

Bioscience ClubhouseCT and Career Ladder Grant

Applications now being accepted. Get the details.
Click Here